ZHEJIANG XINGUANG PHARMACEUTICAL CO., LTD.

Zhejiang Xinguang Pharmaceutical Co., Ltd.

300519

CNE1000027T3

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 24/05/2024 am IST			5-day change	1st Jan Change
12.7 ^CNY	+0.47%		-2.16%	-23.36%

22/05	Zhejiang Xinguang Pharmaceutical Co., Ltd. Announces Final Cash Dividend Plan on A Shares for the Year 2023, Payable on 29 May 2024	CI
25/04	Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Zhejiang Xinguang Pharmaceutical Co., Ltd.(SZSE:300519) added to Shenzhen Stock Exchange Composite Index

July 15, 2016 at 09:30 am IST

Zhejiang Xinguang Pharmaceutical Co., Ltd. has been added to Shenzhen SE Composite index.

Latest news about Zhejiang Xinguang Pharmaceutical Co., Ltd.

Zhejiang Xinguang Pharmaceutical Co., Ltd. Announces Final Cash Dividend Plan on A Shares for the Year 2023, Payable on 29 May 2024	22/05	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21/04	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/23/24	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Approves the Cash Dividend for 2022, Payment on 30 May 2023	23/23/23	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Proposes Profit Distribution for 2022	26/23/26	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24/23/24	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Zhejiang Xinguang Pharmaceutical Expects Q3 Profit to Tumble By Up to 10%	14/22/14	MT
Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22/22/22	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Approves Profit Distribution for 2021, Payable on 26 May 2022	17/22/17	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/22/26	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Proposes Final Dividend for 2021	20/22/20	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/22/25	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	25/21/25	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	25/21/25	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Approves Final Cash Dividend on A Shares for the Year 2020, Payable on May 28, 2021	20/21/20	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Proposes the Final Cash Dividend for 2020	28/21/28	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	27/21/27	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	26/21/26	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	27/20/27	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	25/20/25	CI
Zhejiang Xinguang Pharmaceutical Co., Ltd. Approves Cash Dividend on A Shares for the Year 2019, Payable on 27 May 2020	19/20/19	CI

Chart Zhejiang Xinguang Pharmaceutical Co., Ltd.

Duration

Period

Chart Zhejiang Xinguang Pharmaceutical Co., Ltd.

More charts

Zhejiang Xinguang Pharmaceutical Co Ltd is a China-based company mainly engaged in development, manufacture and sales of Chinese patent medicines, chemical medicines and health foods. The main products of the Company are cardiovascular and cerebrovascular diseases medicine as well as traumatic disease medicine. Its other products include the drugs used in respiratory systems, digestive systems, urinary systems, paediatric diseases and immune systems. The Company operates its businesses mainly in domestic markets, with Zhejiang Province as its major market.

Sector

Pharmaceuticals

Calendar

22/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ZHEJIANG XINGUANG PHARMACEUTICAL CO., LTD.	-23.36%	281M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+18.04%	42.95B
OTSUKA HOLDINGS CO., LTD.	+15.73%	21.38B
SANDOZ GROUP AG	+18.33%	15.05B
CIPLA LIMITED	+19.27%	14.45B
ZYDUS LIFESCIENCES LIMITED	+56.12%	13.04B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-12.84%	6.72B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+11.21%	5.47B

Generic Pharmaceuticals